Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says ... patients would pay less than the cash price for Eli Lilly & Co ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Getting access to popular weight loss drugs will be simpler and cheaper for some. Evernorth, the health services division of The Cigna Group, announced the benefit that will make popular weight ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

The median annual list price for a new drug was over $370,000 in 2024, according to the Reuters survey of 45 medicines. In 2021, the median price was $180,000 for the 30 drugs first marketed ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - Wegovy from ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its pharmacy benefit management plans, the company announced on ...

Only half of health insurer Cigna's clients currently cover the popular GLP-1 weight loss drugs ... a deal with drug makers Ely Lilly and Novo Nordisk which it said will bring prices down for ...

Cigna's pricing compares to the cash-pay market for weight-loss drugs, said Harold Carter, a senior vice president at Evernorth. Sign up here. The $200 co-pays would count toward a patient's ...

The GLP-1 drugs are currently only covered by half of The Cigna Group ... its preferred weight-loss medication. According to analysts, net discounts for employers on list prices range from ...